Prospective human factor validation study of epinephrine prefilled syringe (Symjepi) for the treatment of acute anaphylaxis.

Trial Profile

Prospective human factor validation study of epinephrine prefilled syringe (Symjepi) for the treatment of acute anaphylaxis.

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Mar 2018

At a glance

  • Drugs Epinephrine (Primary)
  • Indications Anaphylaxis
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 13 Mar 2018 New trial record
    • 06 Mar 2018 According to the Adamis Pharmaceuticals Corporation, company provided an update on data presented at the American Academy of Allergy, Asthma, and Immunology (AAAAI) joint congress with the World Allergy Organization.
    • 06 Mar 2018 Results presented in the Adamis Pharmaceuticals Corporation media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top